ASH
Ashland Inc.
NYSE · Basic Materials · Chemicals - Specialty · US
$72.93
−0.37%Aug 24, 2026, 11:00 UTC
Ashland Inc. launched permexa sodium caprate, an intestinal permeation enhancer for oral biologic drug development, announced on August 24, 2026, in Wilmington, Delaware.
Aug 18, 2026, 07:50 UTC
Bank of America Corp DE reduced its stake in Ashland Inc. by 4.9% by selling 22,944 shares during the quarter, according to its Form 13F filing.
Source:Aug 7, 2026, 21:00 UTC
Ashland Inc.'s board of directors declared a quarterly cash dividend of $0.42 per share on the company's common stock on August 7, 2026.
Source:Aug 7, 2026, 20:14 UTC
Ashland is exploring a sale after receiving takeover interest, according to a report.
Source:Aug 7, 2026, 12:08 UTC
Lakshmi Tulasi Inturi has been appointed head of human resources at Wendt India, effective as of the announcement date.
Source:Jul 31, 2026, 00:00 UTC
Ashland Inc. amended its accounts receivable securitization facility, extending the termination date to July 28, 2028 and maintaining maximum commitments of $70 million, with PNC Bank as administrative agent.
Jul 29, 2026, 19:04 UTC
Ashland reported higher sales across all four business units in its fiscal third quarter of 2026.
Source:Jul 29, 2026, 00:30 UTC
Ashland reported Q3 2026 earnings of $1.02 per share, missing the Zacks Consensus Estimate of $1.03 per share and down from $1.04 per share a year ago.
Jul 28, 2026, 19:03 UTC
Ashland is nearing a settlement with activist investor Ancora, which includes adding two board members and establishing a capital allocation committee.
Jun 18, 2026, 14:34 UTC
Activist investor Cruiser Capital is pushing for the sale of Ashland.
Jun 9, 2026, 17:38 UTC
Activist investor Ancora has taken a stake in Ashland.
Source: